3-Chloroplumbagin Induces Cell Death in Breast Cancer Cells Through MAPK-Mediated Mcl-1 Inhibition

Anna Kawiak1, Anna Domachowska1, Aleksandra Krolicka1

  • 1Department of Biotechnology, Intercollegiate Faculty of Biotechnology UG and MUG, University of Gdansk, Gdansk, Poland.

Insights

3-chloroplumbagin (ChPL) combats breast cancer by inhibiting cell proliferation and inducing apoptosis. This natural compound targets the anti-apoptotic Mcl-1 protein via the MAPK signaling pathway, offering a potential new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Acquired resistance to anti-cancer drugs is a major challenge in breast cancer treatment.
  • Apoptosis suppression, often due to upregulated anti-apoptotic Bcl-2 family proteins like Mcl-1, contributes significantly to drug resistance.
  • Mcl-1 is a key therapeutic target for overcoming drug resistance in breast cancer.

Purpose of the Study:

  • To evaluate the antiproliferative effects of 3-chloroplumbagin (ChPL) on breast cancer cells.
  • To investigate the role of Mcl-1 inhibition in ChPL-induced apoptosis.
  • To elucidate the signaling pathways involved in ChPL's anti-cancer activity.

Main Methods:

  • Assessed antiproliferative activity of ChPL on breast cancer cell lines.
  • Investigated ChPL's effect on apoptosis induction and the intrinsic pathway.
  • Examined the involvement of Bcl-2 family proteins, specifically Mcl-1.
  • Analyzed the role of Mitogen-Activated Protein (MAP) kinase signaling, including MEK and ERK phosphorylation.
  • Utilized ERK silencing to assess its impact on ChPL-induced apoptosis and Mcl-1 expression.

Main Results:

  • ChPL demonstrated significant antiproliferative activity against breast cancer cells.
  • ChPL induced apoptosis via the intrinsic pathway, accompanied by downregulation of anti-apoptotic Bcl-2 proteins.
  • Apoptosis induction by ChPL was mediated by the inhibition of MAP kinase signaling, specifically MEK and ERK phosphorylation.
  • Reduced ERK expression enhanced ChPL-induced apoptosis, and ERK silencing led to decreased Mcl-1 expression in ChPL-treated cells.

Conclusions:

  • ChPL induces apoptosis in breast cancer cells through MAP kinase-mediated inhibition of Mcl-1.
  • These findings highlight ChPL's potential as a therapeutic agent for breast cancer, particularly in overcoming Mcl-1-driven drug resistance.
  • Further research is warranted to explore ChPL's clinical applicability in breast cancer treatment.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.6K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K